All Clinical Resources

133 - 144 of 235 results

Treating Community-Acquired Bacterial Pneumonia (CABP): A Systemic Pleuromutilin Antibacterial in the Outpatient Setting

Industry Webcast Sponsored by Nabriva Therapeutics US, Inc.; Not for CME/CE Credit


My Joints Are Killing Me! Opioids vs. NSAIDs for Chronic Pain - Frankly Speaking EP 68

Chronic pain is a difficult but common problem in primary care. Patients are often desperate for any form of relief, and as a result, many are eventually started on opioid analgesics which can be associated with adverse effects. Is it worth it? Listen to this episode to learn about a recent randomized trial that compared opioid to non-opioid management of patients with chronic low back or hip pain or knee pain due to osteoarthritis. Guest: Alan Ehrlich, MD

Chronic pain is a difficult but common problem in primary care. Patients are often desperate for any form of relief, and as a result, many are eventually started on opioid analgesics which can be associated with adverse effects. Is it worth it? Listen to this episode to learn about a recent randomized trial that compared opioid to non-opioid management of patients with chronic low back or hip pain or knee pain due to osteoarthritis.


Antibiotics and Sinusitis – How Long Is Too Long? - Frankly Speaking EP 67

A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more. Guest: Robert A. Baldor, MD, FAAFP

A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more.


Best Evidence Goals for Type 2 Diabetes - Frankly Speaking EP 66

The American College of Physicians supported an evidence-based review of the topic guidelines for type 2 diabetes and concluded clinicians should aim for an A1c goal between 7.0-8.0 and recommended even less aggressive care for those over the age 80 years. Listen to this podcast episode to learn more about these new guidelines. Guest: Alan Ehrlich MD

The American College of Physicians supported an evidence-based review of the topic guidelines for type 2 diabetes and concluded clinicians should aim for an A1c goal between 7.0-8.0 and recommended even less aggressive care for those over the age 80 years. Listen to this podcast episode to learn more about these new guidelines.


Is Screen Time Taking Your Child’s Sleep Time? - Frankly Speaking EP 65

Listen to this podcast episode for a brief summary of the literature on electronic media and its relation to sleep—specifically delayed bedtimes and decreased sleep duration. Screen-based media consumption is eating up our sleep health! Guest: Jill Terrien PhD, ANP-BC

This session will review a brief report summarizing the literature on electronic media and its relation to sleep—specifically delayed bed times and decreased sleep duration. Screen based media consumption is eating up our sleep health!


Diet! Diet! Who’s Got the Best Diet? - Frankly Speaking EP 64

71% of adults in the United States are overweight or obese. To tackle this problem, primary care providers must stay up to date on the best evidence for addressing overweight and obese status in their patients. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern. Guest: Kenneth Peterson, PhD, FNP-BC

71% of adults in the United States are overweight or obese. The impact the medical community is making on reducing high rates of overweight and obesity is less than optimal. Primary care providers (PCPs) bear witness to this staggering statistic on a daily basis and are in a unique position to address this problem. To tackle this problem PCPs must be up to date on best evidence for addressing overweight and obese status in their patients. What seems simple might not be the case. As clinical evidence for best practice in treating overweight and obese patients grows, which approach is considered best. With limited time for patient encounters and higher patient volumes, what health counseling, patient education or behavioral health strategies will work best. With a variety of diets available for patients to choose, which one is preferred. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern.


Changing Immunization Practices: 2-Dose Vaccines - Frankly Speaking EP 63

Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations. Guest: Robert A. Baldor, MD, FAAFP

Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations.


I’ve Got Rhythm: Catheter Ablation Therapy for Patients with Atrial Fibrillation and Heart Failure - Frankly Speaking EP 62

Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes. Guest: Alan Ehrlich MD

Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes.


How to Best Treat Cognitive Impairment – 2018 AAN Recommendations - Frankly Speaking EP 61

In this week’s episode, we’ll be continuing the discussion on the AAN’s updated practice guideline on mild cognitive impairment. Last week’s podcast episode provided an overview of the updated practice guideline, and this week’s episode focuses on treatment recommendations. Guest: Robert A. Baldor, MD, FAAFP

In this week’s episode, we’ll be continuing the discussion on the AAN’s updated practice guideline on mild cognitive impairment. Last week’s podcast episode provided an overview of the updated practice guideline, and this week’s episode focuses on treatment recommendations.


Screening for Dementia; Better Than MMSE (Mini Mental Status Exam) - Frankly Speaking EP 60

The American Academy of Neurology recently published the first updated practice guideline on mild cognitive impairment since 2001. Listen to this week’s episode for an overview of the updated practice guideline, which includes a systematic review of prevalence, prognosis, screening, and treatment research with clear recommendations for practicing clinicians. Guest: Robert A. Baldor, MD, FAAFP

The American Academy of Neurology recently published the first updated practice guideline on mild cognitive impairment since 2001. Listen to this week’s episode for an overview of the updated practice guideline, which includes a systematic review of prevalence, prognosis, screening, and treatment research with clear recommendations for practicing clinicians


GET UP: A Small Bit of Movement Makes a Big Impact - Frankly Speaking EP 59

This observational study found adding very little activity, akin to going for a 30-minute walk or converting to a standing desk for half your workday, lowered all-cause and cardiovascular mortality. Guest: Alan Ehrlich, MD

This observational study found adding very little activity, akin to going for a 30 minute walk or converting to a standing desk for half your workday, lowered all-cause and cardiovascular mortality.


Do We Still Use Warfarin? - Frankly Speaking EP 58

Direct acting oral anticoagulants are increasingly used for stroke prevention for individuals with atrial fibrillation. Whether these agents are as safe and effective as warfarin has been a concern for many clinicians, but recent comparative effectiveness analyses are providing answers. In this week’s podcast episode, we will review these recent studies and draw some conclusions about which agents are best. Guest: Robert A. Baldor, MD, FAAFP

Direct acting oral anticoagulants are increasingly used for stroke prevention for individuals with atrial fibrillation. Whether these agents are as safe and effective as warfarin has been a concern for many clinicians, but recent comparative effectiveness analyses are providing answers. In this week’s podcast episode, we will review these recent studies and draw some conclusions about which agents are best.